Vaxfab Enterprises Intrinsic Value
Vaxfab Enterprises (VEL) median intrinsic value is ₹18.05 from 8 valuation models (range ₹12–₹49), vs current price ₹60.17 — -70.0% downside (Trading Above Calculated Value), margin of safety -100.0%. Analyse Vaxfab Enterprises ownership pattern to track promoter, FII and institutional holdings.
VEL Valuation Methods Summary — DCF, Graham Number & P/E
Vaxfab Enterprises intrinsic value across 8 models vs current price ₹60.17 — upside/downside and value range per method. For current market price and key ratios, visit VEL share price screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹18.05 | ₹14.44 - ₹21.66 | -70.0% | EPS: ₹1.04, Sector P/E: 12x |
| Book Value Method | asset | ₹12.03 | ₹10.83 - ₹13.23 | -80.0% | Book Value/Share: ₹11.00, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹48.80 | ₹43.92 - ₹53.68 | -18.9% | Revenue/Share: ₹61.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹48.00 | ₹43.20 - ₹52.80 | -20.2% | EBITDA: ₹32.00Cr, EV/EBITDA: 6x |
| PEG Ratio Method | growth | ₹18.05 | ₹16.25 - ₹19.86 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹18.05 | ₹16.25 - ₹19.86 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹30.09 | ₹27.08 - ₹33.10 | -50.0% | ROE: 18.2%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹18.05 | ₹16.25 - ₹19.86 | -70.0% | EPS: ₹1.04, BVPS: ₹11.00 |
VEL Intrinsic Value vs Market Price — All Valuation Models
Vaxfab Enterprises fair value range ₹12–₹49 vs current market price ₹60.17 across 8 valuation models. Read VEL dividend growth for the complete payout history and dividend yield track record.
VEL Intrinsic Value Analysis — Undervalued or Overvalued?
Vaxfab Enterprises median intrinsic value ₹18.05, current price ₹60.17 — Trading Above Calculated Value by 70.0%, margin of safety -100.0%.
What is the intrinsic value of VEL?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Vaxfab Enterprises (VEL) is ₹18.05 (median value). With the current market price of ₹60.17, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹12.03 to ₹48.80, indicating ₹12.03 - ₹48.80.
Is VEL undervalued or overvalued?
Based on our multi-method analysis, Vaxfab Enterprises (VEL) appears to be trading above calculated value by approximately 70.0%.
VEL Financial Health — Key Ratios vs Industry Benchmarks
Vaxfab Enterprises financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 168.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 18.2% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | -15.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.20x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
VEL Cash Flow Quality — Operating & Free Cash Flow
Vaxfab Enterprises operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2023 | ₹2 Cr | ₹-4 Cr | Positive Operating Cash Flow | 6/10 |
| March 2022 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |